Literature DB >> 20010912

Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses.

Elizabeth Forbes1, Nicholas van Panhuys, Booki Min, Graham Le Gros.   

Abstract

Improved analytical tools have revealed that the development and expression of a Th2 immune response can be broken down into distinct stages with respect to the cytokine microenvironment that is required. Although IL-4 and its STAT6-signalling pathway are critical for the expression of Th2 effector immune responses in peripheral tissues such as the skin, lung and gut, IL-4 and STAT6 signalling are not required for the initial generation of IL-4-producing Th2 cells in the lymph node. This finding reveals that we have yet to identify the key cytokine or microenvironment that stimulates the development of this most intriguing CD4(+) T-helper subset and emphasises the tissue specificity and timing of IL-4/STAT6-dependent Th2 effector responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010912     DOI: 10.1038/icb.2009.101

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  14 in total

1.  Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated.

Authors:  Julia S Pettersen; Judilyn Fuentes-Duculan; Mayte Suárez-Fariñas; Katherine C Pierson; Alexander Pitts-Kiefer; Linda Fan; Daniel A Belkin; Claire Q F Wang; Shivaprasad Bhuvanendran; Leanne M Johnson-Huang; Mark J Bluth; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2011-02-10       Impact factor: 8.551

2.  Potential Role of Hepatitis C Virus Alternate Reading Frame Protein in Negative Regulation of T-Bet Gene Expression.

Authors:  Dan Yan Zhu; Xiao Zhao Deng; Long Feng Jiang; Wen Xiao; Jia Ping Pei; Bing Jun Li; Chang Jun Wang; Jin Hai Zhang; Qi Zhang; Zhen Xian Zhou; Wei Liang Ding; Xiao Dong Xu; Ming Yue
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.

Authors:  Jason A Dubovsky; Kyle A Beckwith; Gayathri Natarajan; Jennifer A Woyach; Samantha Jaglowski; Yiming Zhong; Joshua D Hessler; Ta-Ming Liu; Betty Y Chang; Karilyn M Larkin; Matthew R Stefanovski; Danielle L Chappell; Frank W Frissora; Lisa L Smith; Kelly A Smucker; Joseph M Flynn; Jeffrey A Jones; Leslie A Andritsos; Kami Maddocks; Amy M Lehman; Richard Furman; Jeff Sharman; Anjali Mishra; Michael A Caligiuri; Abhay R Satoskar; Joseph J Buggy; Natarajan Muthusamy; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2013-07-25       Impact factor: 22.113

4.  IL-13-producing Th1 and Th17 cells characterize adaptive responses to both self and foreign antigens.

Authors:  Eugenio Gallo; Shoshana Katzman; Alejandro V Villarino
Journal:  Eur J Immunol       Date:  2012-07-27       Impact factor: 5.532

Review 5.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

6.  Regulation of DNA replication timing on human chromosome by a cell-type specific DNA binding protein SATB1.

Authors:  Masako Oda; Yutaka Kanoh; Yoshihisa Watanabe; Hisao Masai
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

7.  Multiple signaling pathways are involved in the interleukine-4 regulated expression of DC-SIGN in THP-1 cell line.

Authors:  Changzhong Jin; Lijuan Wu; Jie Li; Meixin Fang; Linfang Cheng; Nanping Wu
Journal:  J Biomed Biotechnol       Date:  2012-05-17

8.  The influence of intrauterine exposure to immunosuppressive treatment on changes in the immune system in juvenile Wistar rats.

Authors:  Joanna Kabat-Koperska; Agnieszka Kolasa-Wołosiuk; Bartosz Wojciuk; Iwona Wojciechowska-Koszko; Paulina Roszkowska; Barbara Krasnodębska-Szponder; Edyta Paczkowska; Krzysztof Safranow; Edyta Gołembiewska; Bogusław Machaliński; Kazimierz Ciechanowski
Journal:  Drug Des Devel Ther       Date:  2016-07-14       Impact factor: 4.162

Review 9.  New Immunotherapy Strategies in Breast Cancer.

Authors:  Lin-Yu Yu; Jie Tang; Cong-Min Zhang; Wen-Jing Zeng; Han Yan; Mu-Peng Li; Xiao-Ping Chen
Journal:  Int J Environ Res Public Health       Date:  2017-01-12       Impact factor: 3.390

10.  MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.

Authors:  Christopher J Oliphant; You Yi Hwang; Jennifer A Walker; Maryam Salimi; See Heng Wong; James M Brewer; Alexandros Englezakis; Jillian L Barlow; Emily Hams; Seth T Scanlon; Graham S Ogg; Padraic G Fallon; Andrew N J McKenzie
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.